← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2004Last known activity
Jan 1, 2026
Timeline
2000s
- Jun 1, 2001
AB Science— Founded
Drugs by trial phase (20 distinct, 39 trials)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Coronavirus Infections
- Gastrointestinal Stromal Tumors
- Mastocytosis
- Mastocytosis, Systemic
- Melanoma
- Motor Neuron Disease
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Psoriasis
- Recurrence
- Sclerosis
Recent trials (40)
- NCT07174492Lead sponsorPhase 3Jan 1, 2026
- NCT05564169Lead sponsorPhase 3Nov 15, 2022
- NCT05449444Lead sponsorPhase 2Jul 1, 2022
- NCT05441488Lead sponsorPhase 3Jun 28, 2022
- NCT05211570Lead sponsorPhase 1/Phase 2Jun 1, 2022
- NCT05047783Lead sponsorPhase 2Nov 23, 2021
- NCT04333108Lead sponsorPhase 3Jun 30, 2020
- NCT04622865Lead sponsorPhase 2Jun 1, 2020
- NCT03127267Lead sponsorPhase 3Sep 1, 2017
- NCT05200169Lead sponsorEarly Phase 1Jul 31, 2017
- NCT03771040Lead sponsorPhase 3Dec 31, 2016
- NCT03556956Lead sponsorPhase 2/Phase 3Jul 15, 2015
- NCT03761225Lead sponsorPhase 3Sep 30, 2014
- NCT03766295Lead sponsorPhase 3Jul 31, 2014
- NCT02490488Lead sponsorPhase 2Apr 1, 2014
Details
- Founded
- Paris, FR Jun 1, 2001
- Last known activity
- Jan 1, 2026